Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Cost-Effectiveness Research Easier Said Than Done, Experts Say

This article was originally published in The Pink Sheet Daily

Executive Summary

Cost effectiveness tracks both the cost and quality of care to arrive at some measure of value. But without standard guidelines, it can be difficult to measure not only relative value, but even relative costs.

You may also be interested in...



Economy Makes Health Reform An Imperative, Center for American Progress Says

The Center for American Progress report shows 14,000 Americans losing health insurance per day.

Economy Makes Health Reform An Imperative, Center for American Progress Says

The Center for American Progress report shows 14,000 Americans losing health insurance per day.

White House Health Official Supports Cost-Effectiveness Research

Jeanne Lambrew, President Obama's top health policy expert, said comparative cost information on medical treatments could be a useful part of overall health care reform

Topics

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel